Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19

Anar Isman,a Andy Nyquist,a,∗ Bailey Strecker,a et. al., Brain Behav Immun Health. 2024 Mar; 36: 100733. doi: 10.1016/j.bbih.2024.100733PMCID: PMC1086240, PMID: 38352659 Abstract A subset of patients experiences persistent fatigue symptoms after COVID-19, and patients may develop long COVID,…[...]